PIK3CD and cancer: Overall, selective inhibitors are optimal to repurpose as adjuvants for bacterial infection treatment because the PI3K isotypes used by the immune system are not ubiquitous throughout the body and the treatment length for bacterial infections is shorter than cancer therapy.